^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IBI-354

    i
    Other names: IBI-354, IBI354
    Associations
    News

    Trials

    Company:
    Innovent Biologics
    Drug class:
    Topoisomerase I inhibitor, HER2-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News

    Trials

    Apply
    A First-in-human Study of IBI354 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors (NCT05636215)
    Phase 1/2
    Innovent Biologics (Suzhou) Co. Ltd.
    Not yet recruiting
    Last update posted :
    12/12/2022
    Initiation :
    01/01/2023
    Primary completion :
    10/15/2024
    Completion :
    07/15/2025
    HER-2
    |
    HER-2 expression
    |
    IBI-354